MedTrace Logo

The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors

NCT03302676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2019-03-14

No results posted yet for this study

Summary

This study evaluates the possible benefits of a tasteless and sugar free chewing gum as a salivary stimulant for head and neck cancer patients treated with curative intended radiotherapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chewing gum

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER

  • Odense Patient Data Explorative Network

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Julie K Kaae, MD · Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-09-30
Completion
2019-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302676 on ClinicalTrials.gov